CHINA PHARMA HOLDINGS, INC. Fair Value, Option, Changes in Fair Value, Gain (Loss)
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Fair Value, Option, Changes in Fair Value, Gain (Loss) of $15.24 thousand for the 0-month period ending 2021-09-09, per its 10-K filed 2023-03-30.
Discontinued › Income Statement › Other Income
us-gaap:FairValueOptionChangesInFairValueGainLoss1 · last filed 2023-03-30
- 2021-09-09: Fair Value, Option, Changes in Fair Value, Gain (Loss) 0 month $15.24K; Fair Value, Option, Changes in Fair Value, Gain (Loss) $15.24K.
| Period end | Fair Value, Option, Changes in Fair Value, Gain (Loss) 0 month | Fair Value, Option, Changes in Fair Value, Gain (Loss) |
|---|---|---|
| 2021-09-09 | $15.24K 10-K · filed 2023-03-30 | $15.24K 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |